Overview

Fluoxetine as a Quit Smoking AID for Depression Prone

Status:
Completed
Trial end date:
2002-01-01
Target enrollment:
Participant gender:
Summary
To test whether adding fluoxetine pharmacotherapy to behavioral cessation treatment improves the depression-prone smoker's ability to quit.
Phase:
N/A
Details
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Fluoxetine